Please assess the completion status of the following clinical trial:

Trial Title: A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetic patients for at least 12 weeks~* HbA1c value between 7.0 and 10.0%~* Body Mass Index (BMI) 20.0 - 45.0 kg/m2~* Investigator adjudicates that a subject is able to discontinue currently taking hypoglycemic agents safely during treatment~Exclusion Criteria:~* Type 1 diabetes mellitus patients~* Serum creatinine \> upper limit of normal~* Proteinuria (albumin/creatinine ratio \> 300mg/g)~* Dysuria and/or urinary tract infection, genital infection~* Significant renal, hepatic or cardiovascular diseases~* Severe gastrointestinal diseases

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- ASP1941 group (Type: EXPERIMENTAL): oral
- placebo group (Type: PLACEBO_COMPARATOR): oral

Based on this trial design, predict the completion outcome and termination type (if applicable).